Acne News

The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.

Nonablative laser therapy plus topical antioxidants significantly decreased post-inflammatory dyschromia associated with acne vulgaris, especially in patients with skin of color, according to a study.

A study on cancer-causing benzene in acne products was Healio Dermatology’s most-read article of October, with coverage from clinical meetings also garnering attention.

New data showed Winlevi reduced oil production, remained stable when used in conjunction with other topical acne medications and improved outcomes in skin of color, Sun Pharma announced in a press release.

In adults with sensitive skin and acne vulgaris, a 2.6% benzoyl peroxide cleanser reduced acne lesions without irritating the skin, according to a study.

ORLANDO — A speaker at the American Society for Dermatologic Surgery Annual Meeting highlighted a set of international consensus recommendations for the use of energy-based devices for acne scar treatment.

A new study confirmed previous findings that acne products containing benzoyl peroxide have high levels of cancer-causing benzene which are not stabilized by encapsulation techniques even at room temperature.

The FDA’s inaction approving sunscreen ingredients as well as studies about endocrine-disrupting chemicals in personal care products and Ozempic’s impact on hidradenitis suppurativa led Healio Dermatology’s most-read articles in September.

Researchers identify two key genes that contribute to the pathogenesis of acne, potentially opening doors for new treatment approaches, according to a study.